Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia - GlobeNewswire https://t.co/MWU0NfSg5B
— Discovery Institute (@discoverynj) March 1, 2019
from Twitter https://twitter.com/discoverynj
February 28, 2019 at 11:38PM
No comments:
Post a Comment